Here are four takeaways:
1. The presentations will focus on the use of silicon nitride composition in various medical applications, from spine to orthopedics.
2. Two of the presentations are titled: “Metal Ions Contribute to the Material Instability of Zirconia Toughened Alumina” and “Differential Bacteria Expression on Silicon Nitride, PEEK, and Titanium Surfaces.”
3. Amedica develops interbody implants manufactured with medical-grade silicon nitride ceramic, and is marketing spinal fusion products.
4. “This scientific data will convincingly demonstrate the serious limitation of other existing biomaterials, while highlighting the advantages of silicon nitride, even as we continue further testing on an improved second generation silicon nitride composition,” said Sonny Bal, MD, MBA, JD, chairman and CEO, Amedica.
More articles on devices:
TransEnterix’s stock goes up as Johnson & Johnson talks potential acquisitions — 5 things to know
Alliqua BioMedical partners with Human Longevity — 5 insights
CTL Medical Corporation acquires nationally recognized medical device company, AccelSPINE
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.